Breast cancer (BC) represents a paradigm of heterogeneity, manifesting as a spectrum of
molecular subtypes with divergent clinical trajectories. It is fundamentally characterized by …

Cancer stem cells are the key link between malignant tumor progression and drug
resistance. This cell population has special properties that are different from those of …

Dormancy in cancer is a clinical state in which residual disease remains undetectable for a
prolonged duration. At a cellular level, rare cancer cells cease proliferation and survive …

Bone metastasis (BM) is a frequent complication associated with advanced cancer that
significantly increases patient mortality. Myeloid-derived suppressor cells (MDSCs) play a …

Objective To explore the mechanism of action of MicroRNAs-34a (miR-34a) and Eurite
growth guiding factor 1 (Netrin1) in cisplatin resistance in gastric cancer (GC), providing new …

Netrins, a family of secreted and membrane‐associated proteins, can regulate axonal
guidance, morphogenesis, angiogenesis, cell migration, cell survival, and tumorigenesis …

Periampullary cancer is a malignant tumor occurring around the ampullary region of the liver
and pancreas, encompassing a variety of tissue types and sharing numerous biological …

Nanoparticle's success as drug delivery systems for cancer treatment has been achieved
through passive targeting mechanisms. However, tumor heterogeneity and rapid drug …

Background/Objectives: Interleukin 13 receptor alpha 2 (IL-13Rα2) is a receptor with a high
affinity for IL-13 and is involved in the progression of human cancers. However, studies on …

Colitis-associated colorectal cancer has been a hot topic in public health issues worldwide.
Numerous studies have demonstrated the significance of myeloid-derived suppressor cells …